𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of intracoronary adenosine for the management of slow–no-reflow phenomenon during percutaneous interventions

✍ Scribed by Murat Özdemir; Mustafa Cemri; Rıdvan Yalçin; Atiye Çengel

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
24 KB
Volume
54
Category
Article
ISSN
1522-1946

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intracoronary adenosine administered dur
Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of “no reflow” phenomenon
✍ Abid R. Assali; Stefano Sdringola; Mohammad Ghani; Ali E. Denkats; Armando Yepes 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB 👁 2 views

Percutaneous intervention in acute myocardial infarction has been associated with a high incidence of "no reflow," ranging from 11% to 30%, with an increased risk of complications. The role of intracoronary adenosine for the prevention of this phenomenon has not been evaluated fully. We studied the

Efficacy of intracoronary nicardipine in
Efficacy of intracoronary nicardipine in the treatment of no-reflow during percutaneous coronary intervention
✍ Raymond I. Huang; Parul Patel; Paul Walinsky; David L. Fischman; J. David Ogilby 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

## Abstract Objectives: The goal of this study was to evaluate the safety and efficacy of nicardipine in reversing no‐reflow during percutaneous coronary intervention (PCI). Background: No‐reflow is a common complication of PCI in patients with acute coronary syndromes or venous bypass graft diseas